Concepedia

Gwen Kurilik

GK

2

Publications

267

Citations

2

H-Index

2002

Active since

Affiliations

Novartis (Switzerland)(Current)

Gwen Kurilik is an author at Novartis (Switzerland).

Publications per year

2002–2003

2

Publications

2

The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML

Michael O’Dwyer, Michael J. Mauro, Gwen Kurilik et al. · Blood · 2002 · 148 citations · Full text

Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate

Michael O’Dwyer, Michael J. Mauro, Carolyn Blasdel et al. · Blood · 2003 · 119 citations · Full text

Rows per page

1–2 of 2